48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.
Azar P, Wong JSH, Mathew N, Ignaszewski MJ, Partovi N, Krausz RM, Ajidahun A, Thotakura S, Harris M, Barrios R, Montaner JSG, Maharaj AR.
Azar P, et al. Among authors: thotakura s.
J Addict Med. 2024 Jan-Feb 01;18(1):82-85. doi: 10.1097/ADM.0000000000001231. Epub 2023 Oct 17.
J Addict Med. 2024.
PMID: 37847573